...
首页> 外文期刊>International journal of oral and maxillofacial surgery >Mandibular reconstruction with prefabricated vascularized bone grafts using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part II: transplantation.
【24h】

Mandibular reconstruction with prefabricated vascularized bone grafts using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part II: transplantation.

机译:使用重组人骨质骨质蛋白-1的预制血管化骨移植的下颌重建:微型猪的实验研究。 第II部分:移植。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Osteogenic Protein-1 (rhOP-1), also called bone morphogenetic protein-7 (BMP-7), is osteoinductive. The aim of this study was to present a new surgical technique: the prefabrication of a vascularized bone graft using rhOP-1 and its microsurgical transplantation. During 6 weeks, osteomuscular grafts were prefabricated in the latissimus dorsi muscle of five adult minipigs. Six hundred micrograms rhOP-1 on a carrier of xenogenic bone mineral in block form were used. The grafts were transplanted into defects of the mandibular angles performing a microsurgical anastomosis and using miniplates for fixation. Identical defects of the contralateral side were treated by direct application of 600 microg rhOP-1 and xenogenic bone mineral. A polychrome sequential labelling was applied. After transplantation the bone stayed viable, demonstrated by continuous apposition of fluorochromes (non-decalcified histologic sections) and bone scintigraphy. The reconstructive result was significantly superior in the prefabrication technique, assessed by histology and computerized tomography (CT). In conclusion, the method has a potential to become a clinical alternative for conventional vascularized bone grafts.
机译:成骨蛋白-1(RHOP-1),也称为骨形态发生蛋白-7(BMP-7),是骨诱导的。本研究的目的是提出新的手术技术:使用RHOP-1的血管化骨移植的预制及其显微外科移植。在6周内,在五个成人微米的Latissimus背部肌肉中预制了骨质移植物。使用六百微克rhop-1在嵌段形式的异丙骨矿物质载体上。移植物移植成具有显微外科吻合术的下颌角度的缺陷,并使用小脂蛋白进行固定。通过直接施用600 microg rhOP-1和异种骨矿物来治疗对侧缺陷。施加多铬序列标记。移植后,骨保持可行,通过荧光染料(非降级的组织物学部分)和骨闪烁术的连续链接证明。通过组织学和计算机断层扫描(CT)评估重组结果在预制技术中显着优异。总之,该方法具有常规血管化骨移植物的临床替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号